As the Managing Director and General Manager of EMD Serono's Canadian operations, Gaby is responsible for ensuring that patients across Canada can benefit from EMD Serono’s innovative therapies in oncology, neurodegenerative diseases, fertility and endocrinology.
Gaby's expertise comes from more than 20 years of leadership experience in biopharmaceuticals, specializing in the area of multiple sclerosis (MS). After working for Teva Pharmaceuticals and launching their MS drug, Gaby joined EMD Serono as National Sales Director in 2000 and for the next six years, helped to grow the organization's MS portfolio.
Before returning to EMD Serono in 2015, Gaby worked for Novartis Canada, where he built therapeutic portfolios in several categories including cardiovascular and neurodegenerative diseases and launched their MS unit. He also served there as the Regional Neuroscience Head for Latin America and Canada and championed treatments for MS, Parkinson's and Alzheimer's diseases. Additionally, Gaby has experience working as a Business Lead in Virology for Bristol Myers Squibb.
Gaby holds a Bachelor of Science degree in Biology, with a minor in Economics, from the Université du Québec à Montréal.
You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.
If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website.